A five-year nationwide registry study finds that stroke and TIA patients discharged on amlodipine showed better functional ...

Blocking calcium channels in brain capillaries may enhance blood flow and alleviate early-stage Alzheimer's damage, new study suggests. Study: Inhibiting Ca 2+ channels in Alzheimer’s disease model ...

Calcium channel blockers may improve treatment for pancreatic cancer patients receiving gemcitabine-based chemotherapy, according to recent findings published in the Proceedings of the National ...

Please provide your email address to receive an email when new articles are posted on . Beta-blockers more effectively reduce risk for death or hospitalization in people with HFpEF compared with ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...

I have found that some patients with depression seem to improve when calcium blockers are discontinued. Are there any data to support this? What would be your preference as a replacement for a calcium ...

New York, May 30, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Calcium Channel Blocker Global Market Report 2023" - https://www ...

The combination of a calcium channel blocker (CCB) and a blocker of the renin–angiotensin–aldosterone system (RAAS) is recommended in clinical practice guidelines. L/N- and L/T-type CCBs might provide ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The "Antihypertensive Drugs Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2035" report has been added to the Credence Research Inc. market intelligence offering.